Companies: 10,795·Total market cap: $144.5T
MedMira Inc.

MedMira Inc.

MIR.VTSXVHealthcare● Active
$0.06
+$0.00(+0.00%)
Market Cap$42103832
P/E Ratio
52W High$0.11
52W Low$0.05

MedMira Inc. (MIR.V) Revenue

Annual & quarterly revenue history · segment & region breakdown

MIR.V · revenue · updated Jun 9, 2026

Core revenue metrics

MedMira Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 41.70% year-over-year from $0.00B in FY2025.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
-41.70%
vs FY2025 $0.00B
Price / sales
223.37×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$4K
52 employees
FY2025
$0.00B
FY2024
$0.00B
5Y CAGR
+-35.4%
Fiscal year end
Dec 31
Currency
CAD · GAAP
Filing
10-K / 10-Q
Source: FMP · MedMira Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

20252006 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-07-31$0.00B-$0.00B-41.70%
2024-07-31$0.00B-$0.00B-4.61%
2023-07-31$0.00B-$0.00B-54.57%
2022-07-31$0.00B-$0.00B-55.60%
2021-07-31$0.00B+$0.00B+133.33%
2020-07-31$0.00B+$0.00B+74.25%
2019-07-31$0.00B-$0.00B-10.43%
2018-07-31$0.00B-$0.00B-21.20%
2017-07-31$0.00B-$0.00B-66.89%
2016-07-31$0.00B-$0.00B-44.31%
MIR.V revenue by year · MIR.V revenue history · MIR.V annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income MedMira Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

MedMira Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.

Data sourced from MedMira Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

MIR.V revenue · 4 questions

MIR.V's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 41.70% year-over-year from $0.00B in FY2025.

MIR.V revenueMIR.V annual revenuewhat is MIR.V revenueMIR.V TTM revenue

Source: FMP · MedMira Inc. SEC filings · GAAP · MedMira Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026